Agilent Technologies IncPiper Sandler initiated coverage with Neutral rating and $150 price target, reflecting cautious view on growth drivers.

Piper Sandler initiated coverage of Agilent Technologies with a Neutral rating and a $150 price target. The firm launched coverage of the life science tools sector, preferring to wait for clearer signs of future growth drivers before turning more positive on additional companies in the space. Piper Sandler noted that challenges related to biotech and academic spending, along with China-related exposure, could improve in the near term. Separately, Agilent announced a strategic collaboration with OpenAI and Boston Consulting Group to expand the use of artificial intelligence across its business operations, product development, and customer solutions.
Agilent Technologies IncPiper Sandler initiated coverage with Neutral rating and $150 price target, reflecting cautious view on growth drivers.
Piper Sandler Companies